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Corrigendum to: The enhancing of a cysteine proteinase activity at acidic pH by protein engineering, the role of glutamic 50 in the
enzyme mechanism of caricain (FEBS 20952)
[FEBS Letters 437 (1998) 91^96]1
Yoshihide Ikeuchi, Nikolaos A. Katerelos, Peter W. Goodenough*
Wolfson Protein Engineering Facility, School of Plant Sciences, Plant Science Laboratories, University of Reading, Reading RG6 6AS, UK
Four minor errors were found in the legends of Figs. 1, 3 and 4 and Table 2 of this paper. They are:
Fig. 1, line 2: BaCl should be NaCl; Fig. 3, line 1: E158A should be D158A; Fig. 4, line 4: equation 7 should read equation 6;
Table 2, line 1: D50A and D50A, D158E should read E50A and E50A, D158E.
FEBS 21081 30-11-98
*Corresponding author. Fax: (44) (1189) 753676.
E-mail: p.w.goodenough@reading.ac.uk
1 PII: S0014-5793(98)01194-6
FEBS 21120
Corrigendum to: Gene-encoded peptide antibiotics and innate immunity. Do ‘animalcules’ have defence budgets? (FEBS 20260)
[FEBS Letters 430 (1998) 130^134]1
Donatella Barraa;*, Maurizio Simmacob, Hans G. Bomanc
aIstituto Pasteur-Fondazione Cenci Bolognetti, Dipartimento di Scienze Biochimiche ‘A. Rossi Fanelli’ and CNR Centro di Biologia Molecolare,
UniversitaØ ‘La Sapienza’, Piazzale Aldo Moro 5, 00185 Rome, Italy
bDipartimento di Scienze Biomediche, UniversitaØ di Chieti, 66100 Chieti, Italy
cMicrobiology and Tumor Biology Center, Karolinska Institutet, Box 280, S-171 77 Stockholm, Sweden
The authors wish to correct a mistake on p. 132, right column, 1.4. The sentence should read:
‘At day 12, no antibiotic-resistant bacteria were found in the ‘saliva’ of the control. The GC-treated frog gave a transient
infection with E. agglomerans (max. 1654 cfu/5 Wl at day 6) and a progressive infection with A. hydrophila (4400 cfu/5 Wl at day 12).
Thus, the normal capacity to adjust an excess of a natural component of the £ora is lost after GC treatment’.
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